They said its unsafe plus not everyone is licensed to administer it
Quick Answer: GLP-1 receptor agonists improve fatty liver disease by reducing liver fat content, improving liver enzymes, and achieving NASH resolution in clinical trials, primarily through weight loss and enhanced insulin sensitivity
Patients who use this type of peptide experience accelerated fat loss, as well as improvements in energy, mood, and sleep
It includes thiamine (Vitamin B1), which helps with energy and brain health, mainly for those with neurological issues
What to expect: Immune rebalancing is a gradual process
At the same time, it promotes fat burning